Literature DB >> 25407935

Carotid artery infusions for pharmacokinetic and pharmacodynamic analysis of taxanes in mice.

Joely D Jacobs1, Elizabeth A Hopper-Borge2.   

Abstract

When proposing the use of a drug, drug combination, or drug delivery into a novel system, one must assess the pharmacokinetics of the drug in the study model. As the use of mouse models are often a vital step in preclinical drug discovery and drug development, it is necessary to design a system to introduce drugs into mice in a uniform, reproducible manner. Ideally, the system should permit the collection of blood samples at regular intervals over a set time course. The ability to measure drug concentrations by mass-spectrometry, has allowed investigators to follow the changes in plasma drug levels over time in individual mice. In this study, paclitaxel was introduced into transgenic mice as a continuous arterial infusion over three hours, while blood samples were simultaneously taken by retro-orbital bleeds at set time points. Carotid artery infusions are a potential alternative to jugular vein infusions, when factors such as mammary tumors or other obstructions make jugular infusions impractical. Using this technique, paclitaxel concentrations in plasma and tissue achieved similar levels as compared to jugular infusion. In this tutorial, we will demonstrate how to successfully catheterize the carotid artery by preparing an optimized catheter for the individual mouse model, then show how to insert and secure the catheter into the mouse carotid artery, thread the end of the catheter out through the back of the mouse's neck, and hook the mouse to a pump to deliver a controlled rate of drug influx. Multiple low volume retro-orbital bleeds allow for analysis of plasma drug concentrations over time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25407935      PMCID: PMC4353391          DOI: 10.3791/51917

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

Authors:  A H Schinkel; U Mayer; E Wagenaar; C A Mol; L van Deemter; J J Smit; M A van der Valk; A C Voordouw; H Spits; O van Tellingen; J M Zijlmans; W E Fibbe; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography-mass spectrometry.

Authors:  K P Bateman; G Castonguay; L Xu; S Rowland; D A Nicoll-Griffith; N Kelly; C C Chan
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-15

3.  The use of capillary high performance liquid chromatography with electrospray mass spectrometry for the analysis of small volume blood samples from serially bled mice to determine the pharmacokinetics of early discovery compounds.

Authors:  I J Fraser; G J Dear; R Plumb; M L'Affineur; D Fraser; A J Skippen
Journal:  Rapid Commun Mass Spectrom       Date:  1999       Impact factor: 2.419

4.  A physiologically based pharmacokinetic model of docetaxel disposition: from mouse to man.

Authors:  Erica L Bradshaw-Pierce; S Gail Eckhardt; Daniel L Gustafson
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

5.  The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.

Authors:  James M Gallo; Shaolan Li; Ping Guo; Karin Reed; Jianguo Ma
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

6.  Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice.

Authors:  J L Eiseman; N D Eddington; J Leslie; C MacAuley; D L Sentz; M Zuhowski; J M Kujawa; D Young; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

Authors:  L Gianni; C M Kearns; A Giani; G Capri; L Viganó; A Lacatelli; G Bonadonna; M J Egorin
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

8.  Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography.

Authors:  A Sparreboom; O van Tellingen; W J Nooijen; J H Beijnen
Journal:  J Chromatogr B Biomed Appl       Date:  1995-02-17

9.  Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

Authors:  A Sparreboom; O van Tellingen; W J Nooijen; J H Beijnen
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

10.  A model of chronic nutrient infusion in the rat.

Authors:  Grace Fergusson; Mélanie Ethier; Bader Zarrouki; Ghislaine Fontés; Vincent Poitout
Journal:  J Vis Exp       Date:  2013-08-14       Impact factor: 1.355

View more
  4 in total

1.  A murine model of targeted infusion for intracranial tumors.

Authors:  Minhyung Kim; Tara A Barone; Natalia Fedtsova; Anatoli Gleiberman; Chandler D Wilfong; Julie A Alosi; Robert J Plunkett; Andrei Gudkov; Joseph J Skitzki
Journal:  J Neurooncol       Date:  2015-09-16       Impact factor: 4.130

2.  Snapshot Photoacoustic Topography Through an Ergodic Relay for High-throughput Imaging of Optical Absorption.

Authors:  Yang Li; Lei Li; Liren Zhu; Konstantin Maslov; Junhui Shi; Peng Hu; En Bo; Junjie Yao; Jinyang Liang; Lidai Wang; Lihong V Wang
Journal:  Nat Photonics       Date:  2020-01-20       Impact factor: 38.771

3.  Analysis of B Cell Migration by Intravital Microscopy.

Authors:  Michael Schnoor; Leopoldo Santos-Argumedo; Daniel Alberto Girón-Pérez; Eduardo Vadillo
Journal:  Bio Protoc       Date:  2020-12-05

4.  Live Imaging of the Lung.

Authors:  Tomasz Brzoska; Tomasz W Kaminski; Margaret F Bennewitz; Prithu Sundd
Journal:  Curr Protoc Cytom       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.